ISRAEL

(Click on the graphs under each topic) Diagnostic Substitution ISRAEL (Click on the graphs under each topic) AD Rate AD Changepoints Vaccines MMR Varicella N/A Polio Hep A N/A Diagnostic Substitution Paternal Age Thimerosal N/A N/A N/A

Data Go back to main page

per 10,000 Birthyear all Jews only rate M F Go back to main page   per 10,000 Birthyear all Jews only rate M F 1986 9.2 12.24501 18.37276 5.52257 1987 9.1 12.47276 21.13453 3.37297 1988 10.7 15.47542 24.07699 6.19474 1989 10.3 15.30009 22.48088 6.86204 1990 10.4 16.65256 27.43684 4.47903 1991 10.1 15.12758 22.27447 6.29464 1992 11.8 17.5984 27.2629 5.28095 1993 13.4 19.55208 29.21689 7.2949 1994 15.1048 24.031 4.89136 1995 13.3 20.76324 33.38107 6.94141 1996 14.7 23.17288 37.8127 6.67491 1997 17.4 25.67124 42.56978 6.50023 1998 16.8 25.81668 42.12151 6.51617 1999 26.77828 43.14498 8.56125 2000 16.6 26.43249 40.70729 9.01144 2001 19 30.49183 47.42286 10.39736 2002 21.8 33.64386 52.74524 9.17652 2003 22.1 36.45459 56.97388 11.86808 2004 34.79429 55.33234 9.46824 2005 15.6 29.20275 24.71769 6.97343 2006 3.3 17.08253 14.6833 3.7529

ASD Changepoint Birthyears 1981 – 2005, 1990.3 Go back to main page

MEASLES, MUMPS, RUBELLA, VARICELLA 12/1988 MMR II Combined measles, mumps and rubella with the RA 27/3 strain Merck >=12 months Replaced the single antigen measles vaccine 12 months-6 years Second dose 1994 2000 Varilrix Varicella virus vaccine, live GSK Approved 1988 Go back to main page

History of Polio vaccine used in Israel Go back to main page History of Polio vaccine used in Israel 1955 IPV – Salk   the Central Virology Laboratory of the Ministry of Health    1,3,30 days 4-6 months Licensed 1957 Program intiation 1961 M1OPV (monovalent type 1)  0-3 years Introduced 1962 M1+M2+M3 OPV 0-3 years 1963-1984 Trivalent OPV 0-1 year 1982 eIPV* + OPV 15 months *Seed viruses were inoculated in cell cultures derived from either secondary or tertiary subcultures of pathogen-free monkey kidney cells or in Vero African green monkey kidney cell lines